Bitcoin Institutional Momentum: ETFs, Whales & Fresh Capital
Franklin Templeton received Nasdaq approval for two Bitcoin DRIP ETFs reinvesting stock dividends into BTC, on-chain data shows fresh capital inflows, and a mystery whale that bought $17B near $58K is still unidentified.
What we know
Franklin Templeton's $1.8T AUM firm received Nasdaq approval for FBEQ and FIBT, two Bitcoin ETFs using a DRIP strategy — reinvesting dividends from US stocks into Bitcoin. On-chain data confirms fresh capital is flowing into Bitcoin, a pattern historically seen only in bull markets. A mystery whale who bought $17B in Bitcoin near $58K remains unidentified — not Strategy, not ETFs. CZ framed 'Bitcoin is dead' calls as historically the best buy signals (1.9k likes). An account on X sees BTC/Gold ratio on the cusp of a major breakout. Against this, the US stock market hit 350% of M2 money supply — highest since the 2000 Dot-Com Bubble — providing a macro backdrop that could boost hard asset narratives.
How the story developed
Franklin Templeton received Nasdaq approval for two Bitcoin DRIP ETFs reinvesting stock dividends into BTC, on-chain data shows fresh capital inflows, and a mystery whale that bought $17B near $58K is still unidentified.
BTC traders are cautious heading into the NY open, with support cited at $78.2k and the asset tracking Nasdaq closely — making macro data and risk-off moves unusually impactful for crypto.
Bitcoin is on its eighth retest of $80k with traders split between adding longs at support and anticipating a short before NY open. In equities, semiconductor ETFs are down 5-7% toward the 200MA and Moderna cratered 18% on a melanoma vaccine data miss.
US equities sold off sharply with NASDAQ 100 hitting -2.9% and Moderna crashing 20%+ before a halt. BTC simultaneously tested its $80k–$81k demand zone with a large long liquidation cluster nearby.
Sources
“Who bought $17 billion in bitcoin near $58K? Not Strategy, not the ETFs”
View post →By the Global Eye 24 desk, with AI assistance. Updated as the story develops. Spot an error? Write to corrections@globaleye24.com.